TherapeuticsMD (TXMD) Non Operating Income (2010 - 2026)
TherapeuticsMD's (TXMD) quarterly Non Operating Income came in at $826000.0 in Q1 2026, up 34.75% YoY from $613000.0 in Q1 2025, and down 15.02% on a QoQ basis from $972000.0 in Q4 2025.
TherapeuticsMD (TXMD) Non Operating Income (2010 - 2026) Analysis & Trends
TherapeuticsMD (TXMD) has 17 years of Non Operating Income data on file, last reported at $826000.0 in Q1 2026.
- Quarterly Non Operating Income rose 34.75% year-over-year to $826000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.0 million (up 8.1% YoY) and the FY2025 annual result came in at $3.7 million, down 0.85% from the prior year.
- Non Operating Income retreated to $826000.0 in Q1 2026, from $972000.0 in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $1.7 million in Q2 2024 to a low of -$22.8 million in Q1 2022.
- A 5-year average of -$834764.7 and a median of $357000.0 in 2023 frame the typical range for Non Operating Income.
- Annual changes were most pronounced in 2022 — Non Operating Income slumped 125.55% — and 2024, when it soared 2898.28%.
- Tracing TXMD's Non Operating Income over 5 years: stood at $11000.0 in 2022, then soared by 145.45% to $27000.0 in 2023, then soared by 2622.22% to $735000.0 in 2024, then surged by 32.24% to $972000.0 in 2025, then retreated by 15.02% to $826000.0 in 2026.
- The last three Non Operating Income figures came in at $826000.0 (Q1 2026), $972000.0 (Q4 2025), and $912000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -224.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 5.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 41.90 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 10.70 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | TherapeuticsMD | 23.54 Mn | 14.35 Mn | - | 980,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 980,000.00 |
| Mar 31, 2026 | 826,000.00 |
| Dec 31, 2025 | 972,000.00 |
| Sep 30, 2025 | 912,000.00 |
| Jun 30, 2025 | 1.24 Mn |
| Mar 31, 2025 | 613,000.00 |
| Dec 31, 2024 | 735,000.00 |
| Sep 30, 2024 | 567,000.00 |
| Jun 30, 2024 | 1.74 Mn |
| Mar 31, 2024 | 333,000.00 |
| Dec 31, 2023 | 27,000.00 |
| Sep 30, 2023 | 339,000.00 |
| Jun 30, 2023 | 58,000.00 |
| Mar 31, 2023 | 357,000.00 |
| Dec 31, 2022 | 11,000.00 |
| Sep 30, 2022 | -112,000.00 |
| Jun 30, 2022 | -16,000.00 |
| Mar 31, 2022 | -22.79 Mn |
| Dec 31, 2021 | 25.35 Mn |
| Sep 30, 2021 | -7.50 Mn |